BioSpace News Archive

CureVac has revealed in its latest financial report that its lung cancer program with German biotechnology company Boehringer Ingelheim has been terminated.

mRNA has built its reputation as a type of vaccine to fight COVID-19, but its capabilities extend beyond vaccines into therapeutics and even diagnostics.

The FDA recommended additional clinical and statistical data analyses of Vicineum, as well as issues related to the company’s Chemistry, Manufacturing, and Controls.

Increase in application of AR in rehabilitation, diagnostic imaging, surgical simulation, and patient care management along with surge in number of AR-based startups propel the growth of the global AR in healthcare market.

Aurinia Pharmaceuticals Inc. announced the addition of two novel assets that will expand the Company’s rare autoimmune and kidney-related disease pipeline.

Eli Lilly and Company announced executive leadership changes and the creation of neuroscience and immunology business units.

TCR2 Therapeutics Inc., a clinical-stage cell therapy company with a pipeline of novel T cell therapies for patients suffering from cancer, announced that their interim update on the Phase 1/2 clinical trial of gavo-cel will be featured in the official Press Programme at the European Society for Medical Oncology.

Quest Diagnostics, the world’s leading provider of diagnostic information services, announced that its Board of Directors has elected Ms. Tracey C. Doi to serve as a director.

Kraig Biocraft Laboratories, Inc., the leading developer of spider silk-based fibers, announces the opening of a new spider silk production factory located in Vietnam.

OncXerna Therapeutics, Inc., a precision medicine company using an innovative RNA-expression based biomarker platform to predict patient responses to its targeted oncology therapies, announced the appointment of Evan Ballantyne as Chief Financial Officer.